November 17, 2015
SAN FRANCISCO — Despite powerful new medications, the lack of screening and treatment capacity will make it
difficult to eliminate the hepatitis C virus in the United States, according to projections presented here at the Liver Meeting 2015.
Current trends show that even after 2020, more than 500,000 people will be unaware that they are infected with
hepatitis C, said Jagpreet Chhatwal, PhD, from the Massachusetts General Hospital and Harvard Medical School in Boston.